PrEP: latest news

PrEP resources

  • How to get PrEP in the UK

    NHS services in the UK cannot currently provide PrEP.But it is legal to buy PrEP drugs online and import them for your personal use.To use PrEP safely, you...

    From: Factsheets

    Information level Level 2
  • Pre-exposure prophylaxis (PrEP)

    PrEP is highly effective in preventing the sexual transmission of HIV. For PrEP to work well, it’s important to take the pills regularly.While PrEP can...

    From: Factsheets

    Information level Level 2
  • Using anti-HIV drugs to prevent HIV

    The goal of HIV treatment is an undetectable viral load. An undetectable viral load means that your blood has a level of HIV below the level which...

    From: Booklets

    Information level Level 2
  • PrEP

    This briefing paper provides an overview of pre-exposure prophylaxis (PrEP) for people planning, commissioning or providing HIV prevention activities in the UK. It does this by reviewing...

    From: HIV prevention briefing papers

  • Pre-exposure prophylaxis

    Pre-exposure prophylaxis is an experimental HIV-prevention strategy that would use antiretrovirals (ARVs) to protect HIV-negative people from HIV infection....

    From: Preventing HIV

    Information level Level 4

PrEP features

PrEP news from aidsmap

More news

PrEP news selected from other sources

  • PrEPster joins call for PrEP for women

    PrEPster today joined with other leading PrEP advocate organisations in calling for PrEP for women in the UK.

    17 hours ago | Prepster
  • Australia: PrEP listing decision deferred

    An HIV prevention advocate has vowed to keep fighting for pre exposure prophylaxis to be PBS listed. The decision was deferred in order to seek further information regarding cost-effectiveness.

    19 hours ago | Australian Journal of Pharmacy
  • How PrEP changed Matt's life

    The arrival of HIV/Aids in the 1980s had a devastating effect on gay communities around the world. Sexual intercourse was linked to the risk of contracting a deadly disease. We explore how pre-exposure prophylaxis (PrEP) has changed Matt's attitudes to sex.

    19 hours ago | BBC (video)
  • PrEP impact trial questions and answers

    NHS England has announced the start of a pioneering implementation trial to provide HIV prevention drugs to people at high risk of HIV infection.

    19 hours ago | NHS England
  • Men on PrEP & HIV-positive men are getting hepatitis C during sex—here’s why

    Hepatitis C is best known as an infection transmitted by blood, with most new cases of hepatitis C caused by sharing injection drug use equipment. But this dangerous infection, which … Read More →

    18 August 2017 | BETA blog
  • How a Blue Pill Is Stopping the Spread of HIV

    Gilead’s Truvada is preventing HIV, driving cases to 1980s low.

    18 August 2017 | Bloomberg
  • Mylan launches 3 HIV generics in Canada

    Mylan has launched three generics for treating HIV in Canada. Among the three launches is the company’s generic of Gilead’s Truvada (emtricitabine/tenofovir disoproxil fumarate, 200 mg/300 mg), as well as generics of Atripla (efavirenz, emtricitabine and tenofovir disoproxil fumarate, 600 mg/200 mg/300 mg) and Viread (tenofovir disoproxil, 300 mg).

    11 August 2017 | Drug Store News
  • Can new 'Smart PrEP Pills' increase adherence for HIV-prevention medication among young people?

    Researchers at Cook County Health and Hospitals System are currently recruiting participants in a study to see if, as expected, the smart PrEP pill makes it easier for young people to keep track of their PrEP dosage each day and in the process, significantly reduce their chances of getting HIV/AIDS.

    08 August 2017 | Chicago Daily Herald
  • In first, healthcare provider to subsidize HIV medication

    The decision by Meuhedet to subsidize a generic version of the drug Truvada is set to drive a dramatic drop in prices for HIV medication. Under the new policy, Meuhedet patients were expected to pay NIS 300-500 ($83-$138) for the medication instead of the current cost of some NIS 2,100 ($580).

    08 August 2017 | The Times of Israel
  • Breakthrough HIV drug: Authorities reconsider decision to block cheap access

    People at high risk of HIV could soon get cheap access to a breakthrough preventative drug as federal health authorities revisit their decision to refuse a taxpayer subsidy.

    07 August 2017 | The Sydney Morning Herald
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.